Glomerulonephritis: Types, Causes, Diagnosis & Treatment of Kidney Filter Inflammation

Glomerulonephritis (GN) is inflammation of the glomeruli — the kidney's microscopic filtering units. It impairs filtration, causing hematuria, proteinuria, hypertension, and renal dysfunction. GN can be acute, chronic, or rapidly progressive (RPGN).

Classification

By Etiology

  • Primary (intrinsic renal): IgA nephropathy (most common), FSGS, membranous, minimal change, MPGN, anti-GBM.
  • Secondary (systemic): Lupus nephritis, vasculitis (ANCA, cryoglobulinemic), diabetic nephropathy, amyloidosis, infections (post-strep, endocarditis, hepatitis B/C, HIV).

By Histology (Light Microscopy)

  • Proliferative (endocapillary, mesangial): IgA, post-strep, lupus Class III/IV, MPGN.
  • Sclerosing: FSGS, chronic hypertensive, diabetic.
  • Crescentic (RPGN): >50% glomeruli with crescents — Types I (anti-GBM), II (immune complex), III (pauci-immune/ANCA).

By Clinical Syndrome

  • Nephritic: Hematuria, RBC casts, hypertension, oliguria, mild proteinuria (<3.5g), azotemia.
  • Nephrotic: Heavy proteinuria (>3.5g), hypoalbuminemia, edema, hyperlipidemia, lipiduria.
  • Asymptomatic urinary abnormalities: Isolated hematuria/proteinuria.
  • Rapidly progressive (RPGN): Rapid GFR decline (days–weeks); crescents on biopsy.

Key Causes

  • Infections: Post-strep (children), endocarditis (shunt nephritis), hepatitis B/C, HIV, malaria.
  • Autoimmune: SLE, ANCA vasculitis (GPA, MPA), anti-GBM (Goodpasture), IgA nephropathy.
  • Genetic: Alport (COL4A3–5), CFHR5, complement mutations (aHUS, C3G).
  • Drugs: NSAIDs (minimal change, interstitial), gold, penicillamine, checkpoint inhibitors.
  • Malignancy: Paraneoplastic (membranous), infiltration.

Diagnosis

  • Urinalysis: dysmorphic RBCs, RBC casts, proteinuria.
  • Serology: ANA, ANCA, anti-GBM, complements (C3, C4), cryoglobulins, hepatitis, HIV, SPEP.
  • Kidney biopsy: definitive for type, activity, chronicity, prognosis (except clear clinical syndromes).

Treatment Principles

  • Supportive: BP control (ACEi/ARB first-line), volume management, lipid control, CVD risk reduction.
  • Disease-specific immunosuppression:
    • IgA: supportive; steroids/fish oil if progressive; sparsentan (new).
    • Lupus: MMF/cyclophosphamide + steroids; belimumab, voclosporin.
    • ANCA: rituximab/cyclophosphamide + steroids; avacopan.
    • Anti-GBM: plasmapheresis + cyclophosphamide + steroids (urgent).
    • Minimal change: steroids (high response); CNI for frequent relapse.
    • FSGS: steroids; CNI, rituximab, sparsentan if resistant.
  • RPGN: Medical emergency — pulse steroids + cyclophosphamide/rituximab ± plasmapheresis.

Prognosis

  • Variable: minimal change (excellent), IgA (30–40% ESRD at 20 yr), FSGS (variable), RPGN (depends on speed of treatment).
  • Early diagnosis + targeted therapy preserves kidney function.

GN is a histologic diagnosis with diverse causes. Nephrology referral for persistent hematuria/proteinuria, active sediment, or unexplained AKI is essential.

Kidney Disease - Related Articles